Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
247.15Prev. Close
249.65Volume
56,536Total traded value
1.41 CrUpper Circuit
299.55Lower Circuit
199.75Fundamentals
| Market Cap | ₹820Cr |
| ROE | 51.51% |
| P/E Ratio(TTM) | 19.08 |
| EPS(TTM) | 13.07 |
| P/B Ratio | 15.36 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.77 |
| Book Value | 16.24 |
| Debt to Equity | 2.98 |
| Face Value | 10 |
Understand Fundamentals
Financials
About WANBURY Limited
Wanbury Limited is a pharmaceutical company working in Active Pharmaceutical Ingredients (API) and Domestic Formulations, maintaining a strong position in the cold and cough segment. The company's core philosophy is to achieve transparency, accountability, and fairness in all dealings with its various stakeholders, including investors, customers, and employees. It is one of the largest global manufacturers of Metformin, commanding over 10% of the world's market share.;
| Parent Organisation | WANBURY Limited |
| Managing Director | NA |
| NSE Symbol | WANBURY |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 103.18 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.33 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.60 | ||
| Wockhardt | NA (0.00%) | -195.86 |